Company profile
Accuray Incorporated
NASDAQ: ARAY · Healthcare · Medical - Devices
#219 of 1,422 Healthcare companies by revenue46th-percentile growth
EA Score
68BFH 62DQ 89GM 42SS 72
v0.1 · 65/100 weight · provisional
↑ filing timeliness, disclosure history · ↓ Piotroski F, growth stability
Methodology →Revenue TTM
$428.6M
Rev growth YoY (TTM)
-7.9%
Net income (FY)
-$1.6M
Employees
990
as of 2026-08-20
Market cap
$35.1M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$458.5M$458.5M2025
Net income-$1.6M-$1.6M2025
Operating income$7.8M$7.8M2025
Total assets$470.2M$470.2M2025
Liabilities$389.1M$389.1M2025
Equity$81.2M$81.2M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product52%
Service48%
By geography
Europe India Middle East And Africa31%
CHINA27%
Americas19%
JAPAN12%
Asia Pacific10%
The read
What is Accuray Incorporated’s revenue?
Accuray Incorporated booked $458.5M in FY2025 revenue, growing 2.7% year over year — about the middle of the pack among Healthcare companies we track, at a -0.3% net margin.
Peers · Healthcare
Travere Therapeutics, Inc.74BPhreesia, Inc.68BAyr Wellness Inc.——Tarsus Pharmaceuticals, Inc.62CArtivion, Inc.80B+Atlantic International Corp.39DNeighbors
Dane →Key facts
CEOStephen R. LaNeve
SectorHealthcare
IndustryMedical - Devices
HeadquartersMadison, WI
ExchangeNASDAQ: ARAY
Employees990
IPO date2007-02-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.